Cost-effectiveness analysis for clinical procedures in oncology

Area of Science:

• Health economics
• Healthcare resource allocation
• Decision analysis

Background:

• Medical care provision is resource-intensive, with limited available funds.
• Healthcare resource allocation decisions are made across various system levels.
• Current allocation strategies may not maximize health benefits from expenditures.

Purpose of the Study:

• To evaluate the effectiveness of cost-benefit and cost-effectiveness studies in guiding healthcare resource allocation.
• To identify reasons for the non-acceptance of analyses by healthcare decision-makers.
• To emphasize the importance of including all relevant factors, including subjective judgments, in analyses.

Main Methods:

• Review of existing cost-effectiveness and benefit-cost studies.
• Analysis of factors influencing the acceptance of economic evaluations by decision-makers.
• Examination of the role of analysts in cost-effectiveness studies.

Main Results:

• Many cost-effectiveness and benefit-cost studies have been conducted.
• Analyses are often rejected due to omitted critical factors or issues.
• Analysts may avoid uncertainties and subjective value judgments.

Conclusions:

• Cost-effectiveness analysis must clarify, not obscure, all relevant factors, including subjective value judgments.
• Accurate resource allocation requires incorporating all elements that influence decision-making.
• The analyst's role is crucial in highlighting these factors to improve decision-making.